CODX vs LDOS
Co-Diagnostics, Inc. Common Stock (CODX) versus Leidos Holdings Inc (LDOS) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
Leidos Holdings Inc (LDOS) is a information technology services company listed on US.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported LDOS revenue for 2025-01-03 was $16.66B. Net income was $1.25B. Revenue was up 7.9% from 2023-12-29 to 2025-01-03. LDOS currently screens at market cap $20.04B and trailing P/E 15.7.
CODX currently screens at market cap $31.4M. LDOS currently screens at market cap $20.04B and trailing P/E 15.7.
Not investment advice. Open the CODX and LDOS stock pages for the full models.
Not investment advice.